Li Wenping, Pretner Ewald, Shen Liya, Drieu Katy, Papadopoulos Vassilios
Department of Cell Biology, Georgetown University Medical Center, Washington, DC 20057 USA.
Cell Mol Biol (Noisy-le-grand). 2002 Sep;48(6):655-62.
The standardized extract of Ginkgo biloba leaves (EGb 761) has been shown to inhibit aggressive human breast cancer cell proliferation both in vitro and in vivo. These results were extended to human glioma and hepatoma cells in vitro suggesting that EGb 761 may have a more widespread application for tumor growth control. To understand the mechanism by which EGb 761 acts to inhibit cell proliferation, we investigated the effects of EGb 761 on human breast cancer, glioma and hepatoma cell transcriptomes by means of various large-scale DNA array techniques. The data presented focus on genes regulated by EGb 761 that are common to the three tumor cell types and for which the data were verified by two different types of DNA microarray and/or RNA (Northern) blot analysis and real-time quantitative PCR. These results could therefore help elucidate the mechanism of cytostatic action of EGb 761 and identify genes important for tumor growth.
银杏叶标准化提取物(EGb 761)已被证明在体外和体内均能抑制侵袭性人乳腺癌细胞的增殖。这些结果在体外扩展至人胶质瘤和肝癌细胞,表明EGb 761在控制肿瘤生长方面可能有更广泛的应用。为了解EGb 761抑制细胞增殖的作用机制,我们通过各种大规模DNA阵列技术研究了EGb 761对人乳腺癌、胶质瘤和肝癌细胞转录组的影响。所呈现的数据聚焦于EGb 761调控的基因,这些基因在三种肿瘤细胞类型中是共有的,并且其数据通过两种不同类型的DNA微阵列和/或RNA(Northern)印迹分析以及实时定量PCR得到了验证。因此,这些结果有助于阐明EGb 761的细胞生长抑制作用机制,并确定对肿瘤生长重要的基因。